Microfluidic Immunoassay Market Size, Share, Trends & Forecast

Microfluidic Immunoassay Market is gaining momentum as diagnostic technologies move toward smaller, faster, and more integrated testing platforms. Microfluidic immunoassays combine antibody-based detection with miniature fluid-handling systems, allowing several laboratory steps to be performed within compact devices. This approach can reduce sample and reagent requirements while supporting automation and rapid analysis.

Point-of-care testing is one of the major areas creating opportunities for the technology. Compact microfluidic systems can bring testing closer to patients and may be useful in hospitals, emergency settings, primary care, and decentralized healthcare environments. Their portability and ability to work with small sample volumes make them attractive for situations where conventional laboratory infrastructure is not immediately available.

The technology is also finding applications in biomarker detection, infectious disease testing, cardiology, oncology, and pharmaceutical research. Both electrochemical and optical detection approaches are being developed, while multiplexed testing can allow several biomarkers to be evaluated from a limited sample.

Future growth will depend on improvements in chip design, assay reliability, manufacturing scalability, and integration with portable diagnostic instruments. As healthcare providers continue looking for quicker and more accessible testing methods, microfluidic immunoassays could become increasingly important in decentralized diagnostics and laboratory-on-chip applications.

Read More
Lukoon https://lukoon.com